ArticleNews reportPHN-00032026-10-28 16:12 CT
Regulators review expanded cardiovascular labeling for semaglutide
Source · Reuters
TLDR
A label expansion is under review based on cardiovascular outcomes data.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
No related news yet.